BioSpace News Archive

Supports U.S. Market Introduction of SuperSaturated Oxygen Therapy for Improved AMI Patient Outcomes

Move Reflects Focus on Advancing Several Intranasal Vaccines to Human Studies

athenahealth, Inc. (NASDAQ: ATHN), a leading provider of network-enabled services for hospital and ambulatory customers nationwide, today confirmed that it has received an unsolicited proposal from Elliott Management to acquire the Company for $160 per share in cash.

Augmenix, Inc. is pleased to announce that the Geisinger Health Plan and the military payer TRICARE have joined the growing list of insurers now covering the company’s leading product, SpaceOAR hydrogel.

Pharmaceutical veteran to lead Cumberland’s Hospital Sales Force

-- Introduced XmAb® IL15 Bispecific Antibody Platform and Presented Preclinical Data on XmAb®24306 at American Association for Cancer Research (AACR) Annual Meeting -- - Completed Public Offering, Raising $245.5M and Extending Cash Runway into 2023 - -- Expect to Initiate Phase 3 Trial of XmAb®5871 in IgG4-Related Disease (IgG4-RD) and to Announce Initial Clinical Data from Two Ongoing Clinical Trials in 2H18 -- - Management to Host Conference Call at 4:30 pm ET today -

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today reported financial results for the three months ended March 31, 2018.

Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chief Commercial Officer William Meury will present at the Bank of America Merrill Lynch Healthcare Conference in Las Vegas, Nevada.

--Adjusted EPS Higher Than Expected; Outlook for Fiscal 2018 Net Sales and Adjusted Profitability Affirmed--

Medical and Value Hearing Health Performance Drive Double-Digit First Quarter Sales Gains and Profitability